| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/02/2006 | US7037654 Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents |
| 05/02/2006 | US7037502 Peptide for use in the treatment of inflammation |
| 04/27/2006 | WO2006043079A2 Compositions and methods for the control of mammary cell number |
| 04/27/2006 | WO2006042661A2 Oligopeptides and their use in cosmetics |
| 04/27/2006 | WO2006042655A1 Desoxo-nonadepsipeptides |
| 04/27/2006 | WO2006042654A1 Substituted nonadepsipeptides |
| 04/27/2006 | WO2006042653A1 Heterocyclyl-substituted nonadepsipeptides |
| 04/27/2006 | WO2005092365A3 Pharmaceutical use of novispirins |
| 04/27/2006 | WO2005087792A3 Materials and methods relating to the treatment of glioblastomas |
| 04/27/2006 | US20060090223 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 04/27/2006 | US20060089489 Adding a conductor (optionally metal-plated gold particle) to a the smino groups of a nanofiber formed though self-assembly of a short peptide having a specific sequence |
| 04/27/2006 | US20060089488 Artificially synthesized antimicrobial peptide having antimicrobial property against at least one type of bacteria, where peptide comprises an amino acid sequence composed of at least part of a nuclear diffusion inhibitory signal sequence included in Rev-protein derived from human immunodeficiency virus |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089307 Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
| 04/27/2006 | US20060089298 Novel substances k01-b0171 and process for producing the same |
| 04/27/2006 | US20060088889 screening the peptide library of chemically synthesized peptides, each of the peptides comprising an N-terminal or C-terminal amino acid associated with enzymatic or chemical cleavage of a polypeptide for biological activity; e.g. screening for Clostridium perfringens growth inhibitors or enhancers |
| 04/27/2006 | US20060088878 Purification of recombinant proteins fused to multiple epitopes |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | DE102004051025A1 Substituierte Nonadepsipeptide Substituted nonadepsipeptides |
| 04/27/2006 | DE102004051024A1 Heterocyclyl-substituierte Nonadepsipeptide Heterocyclyl-substituted nonadepsipeptides |
| 04/27/2006 | CA2584915A1 Desoxo-nonadepsipeptides |
| 04/26/2006 | EP1649036A1 Method for producing cyclic molecules |
| 04/26/2006 | EP1648934A2 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 04/26/2006 | EP1648925A1 Bicyclic peptide imaging agents |
| 04/26/2006 | EP1648492A2 A novel antiproliferative factor and methods of use |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | CN1764573A Lock for a flat and low pourer provided with a removable element in the form of a laminate of film for a composite package for container openings closed by a nonpermeable film |
| 04/26/2006 | CN1763093A Survivin mutant containing HIV transduction structural area and its preparation method and uses |
| 04/26/2006 | CN1763084A High purity cyclosporin A preparation method |
| 04/26/2006 | CN1763083A Cyclopentapeptide extraction method and its uses in preparing anti-tumour medicine |
| 04/26/2006 | CN1763082A Screening and authentication of polypeptide binding specificly to tumour tranferring cell |
| 04/26/2006 | CN1253572C Isolated peptides which bind to HLA-C molecules and uses thereof |
| 04/26/2006 | CN1253468C Estrogen-growth hormone release peptide possessing the function of resisting osteoporosis |
| 04/25/2006 | US7034110 Method of identifying chemical compounds having selected properties for a particular application |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034106 Pro1159 polypeptides |
| 04/25/2006 | US7034004 Peptide for controlling appetite |
| 04/25/2006 | US7034002 Angiotensin converting enzyme inhibitor |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/20/2006 | WO2006041829A2 Antagonist peptides to the c5a chemotactic function of vitamin d binding protein |
| 04/20/2006 | WO2006041631A2 Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| 04/20/2006 | WO2006040958A1 Epitope peptide to polymyalgia rheumatica disease antibody and testing reagent for polymyalgia rheumatica disease |
| 04/20/2006 | WO2006040157A1 Anti-angiogenic peptide |
| 04/20/2006 | WO2005120588A3 Peptides delivered to cell nuclei |
| 04/20/2006 | WO2005047314A3 Fgf-beta binding and supported peptides |
| 04/20/2006 | US20060084789 Immunotherapeutic and immunoprphylactic reagents |
| 04/20/2006 | US20060084610 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 04/20/2006 | US20060084609 Synthetic HLA binding WT-1 peptide analogues and uses thereof |
| 04/20/2006 | US20060084608 Binding polypeptides and methods based thereon |
| 04/20/2006 | US20060084596 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis |
| 04/20/2006 | US20060084592 Peptide boronic acid inhibitors |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | US20060083685 Opioid metallopeptide compositions and methods |
| 04/20/2006 | CA2582083A1 A counterion exchange process for peptides |
| 04/19/2006 | EP1647556A1 Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors |
| 04/19/2006 | EP1646651A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 04/19/2006 | EP1646643A2 C5a receptor antagonists |
| 04/19/2006 | EP1646642A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/19/2006 | EP1531846A4 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 04/19/2006 | EP1476427A4 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 04/19/2006 | EP1121381B1 Zinc finger binding domains for gnn |
| 04/19/2006 | EP1103561B1 Hla-a2 restraint tumor antigen peptide originating in sart-1 |
| 04/19/2006 | EP1039934B1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/19/2006 | EP0912733B1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
| 04/19/2006 | EP0873417B1 Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/19/2006 | CN1761679A Peptide fragment of LYVE-1 and antibody against the same |
| 04/19/2006 | CN1760172A Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 04/19/2006 | CN1252085C Peptide as VEGF receptor KDR antagonist |
| 04/18/2006 | USRE39071 Anhydro-and isomer-a-21978c cyclic peptides |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030081 Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N- terminal 1-7 fragment of the CGRP (calcitonin gene related peptide), activates neuronal nicotinic receptor, therefor useful for therapy of neurological disorders |
| 04/13/2006 | WO2006039326A2 Inhibitors of hepatitits c virus |
| 04/13/2006 | WO2006039164A2 Novel cyclosporin analogues and their pharmaceutical uses |
| 04/13/2006 | WO2006039163A2 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006006074A3 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 04/13/2006 | US20060079445 CaMKII/calcium channel binding-related compositions and methods |
| 04/13/2006 | US20060078969 Regulated transcription of targeted genes and other biological events |
| 04/13/2006 | US20060078943 Method for obtaining anti-idiotype antibodies |
| 04/13/2006 | US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 04/13/2006 | CA2583494A1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| 04/13/2006 | CA2583431A1 Variant amyloid protein |
| 04/13/2006 | CA2582095A1 Inhibitors of hepatitis c virus |
| 04/13/2006 | CA2581564A1 Compounds that modulate trh actions |
| 04/12/2006 | EP1645565A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644382A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/12/2006 | EP1644021A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 04/12/2006 | EP1643959A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0866878B1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 04/12/2006 | CN1758925A Methods of radiofluorination of biologically active vectors |
| 04/12/2006 | CN1250722C Method for secretion and prodn. of protein |
| 04/12/2006 | CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms |